The Confusing Terminology of "Medical Cannabis" and Cannabinoid Products.

IF 4.2 3区医学 Q1 SUBSTANCE ABUSE

Journal of Addiction Medicine Pub Date : 2025-03-03 DOI:10.1097/ADM.0000000000001471

Jennifer A Ross, William Riccardelli, Sharon Levy

引用次数: 0

Abstract

With the expansion of the "medical cannabis" or "medical marijuana" market, there is significant confusion surrounding cannabinoid terminology. This commentary provides definitions for cannabinoid terminology, examines US Food and Drug Administration (FDA)-approved and non-FDA-approved medications with cannabinoids as the main ingredient, and discusses how vague terminology may lead to a public misperception regarding the lack of evidence-based medical indications for cannabis.

查看原文本刊更多论文

“医用大麻”和大麻素产品的混淆术语。

随着“医用大麻”或“医用大麻”市场的扩大，围绕大麻素的术语存在重大混淆。本评论提供了大麻素术语的定义，审查了美国食品和药物管理局（FDA）批准和非FDA批准的以大麻素为主要成分的药物，并讨论了模糊的术语如何导致公众对大麻缺乏循证医学适应症的误解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Addiction Medicine 医学-药物滥用

CiteScore

6.10

自引率

9.10%

发文量

260

审稿时长

>12 weeks

期刊介绍： The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including: •addiction and substance use in pregnancy •adolescent addiction and at-risk use •the drug-exposed neonate •pharmacology •all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances •diagnosis •neuroimaging techniques •treatment of special populations •treatment, early intervention and prevention of alcohol and drug use disorders •methodological issues in addiction research •pain and addiction, prescription drug use disorder •co-occurring addiction, medical and psychiatric disorders •pathological gambling disorder, sexual and other behavioral addictions •pathophysiology of addiction •behavioral and pharmacological treatments •issues in graduate medical education •recovery •health services delivery •ethical, legal and liability issues in addiction medicine practice •drug testing •self- and mutual-help.